CERo Therapeutics Holdings, Inc. (CERO)

CERO Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jun 30, 2021
Selling, General & Admin	8.55	8.08	9.12	2.39	2.84	0
Research & Development	9.81	10.38	7.08	5.29	-	-
Other Operating Expenses	-	-	-	-	2.97	-
Total Operating Expenses	18.36	18.46	16.2	7.68	5.81	0
Operating Income	-18.36	-18.46	-16.2	-7.68	-5.81	-0
Interest Income	-	-	-	-	2.84	-
Interest Expense	-0.17	-	-	-	-	-
Other Non-Operating Income (Expense)	-1.57	-1.46	7.89	0.39	-	-
Total Non-Operating Income (Expense)	-1.74	-1.46	7.89	0.39	2.84	-
Pretax Income	-20.09	-19.92	-8.3	-7.29	-0.07	-0
Provision for Income Taxes	-	-	-	-	-0.6	-
Net Income	-20.7	-19.92	-8.3	-7.29	-0.67	-0
Net Income Attributable to Preferred Dividends	28.23	75.61	2.78	-	-	-
Net Income to Common	-90.07	-95.53	-11.09	-7.29	-0.67	-0
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	11	4	0	-	-	-
Shares Outstanding (Diluted)	11	4	0	-	-	-
Shares Change	4299.74%	14499.98%	-	-	-	-
EPS (Basic)	-20.65	-22.58	-363.00	-	-	-
EPS (Diluted)	-20.65	-22.58	-363.00	-	-	-
EPS Growth	-	-	-	-	-	-
Free Cash Flow	-	-16.08	-12.92	-5.79	-1.09	0
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Per Share	-	-3.80	-445.81	-	-	-
EBITDA	-18.36	-18.18	-15.76	-7.21	-5.81	-0
EBIT	-18.36	-18.46	-16.2	-7.68	-5.81	-0
Effective Tax Rate	-	0.00%	0.00%	0.00%	873.70%	0.00%

Data Source: Fiscal.ai Last updated: May 15, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 28, 2026

Data Sources Report a data error